{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-24-003602","form_type":"8-K","ticker":"LFWD","cik":"0001607962","company_name":"Lifeward Ltd.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.956083+00:00","generated_at":"2026-05-30T01:56:58.403137+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeward Q3 rev $6.1M (+39% YoY); net loss narrows to $3.1M; FY guidance $25M-$26M","bullets":["Revenue $6.1M, up 39% vs $4.4M in Q3 2023; ReWalk sales up 173% to $2.5M.","Net loss $3.1M ($0.35/share) vs $7.5M ($0.88) prior year; adjusted net loss $4.0M ($0.45).","Gross margin 36.2% vs 19.6% (adjusted 42.5% vs 45.1%); cash $10.7M, no debt.","FY2024 revenue guidance revised to $25M-$26M; expects highest quarterly revenue in Q4.","Announced cost savings: closing two U.S. facilities, saving ~$3M op expenses; 40 AlterG NEO units ordered."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-24-003602","json":"https://secwatch.observer/filing/0001178913-24-003602.json","markdown":"https://secwatch.observer/filing/0001178913-24-003602.md","text":"https://secwatch.observer/filing/0001178913-24-003602.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607962/000117891324003602/0001178913-24-003602-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607962/000117891324003602/zk2432284.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:56:58.403137+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}